TGA Financial Contents

Therapeutic Goods Administration

Statement by the Secretary, National Manager and Chief Financial Officer

Income Statement

Balance Sheet

Statement of Cash Flows

Statement of Changes in Equity

Schedule of Commitments

Schedule of Contingencies

Notes to and forming Part of the Financial Statements

Note	Description
1.	Summary of significant accounting policies - notes 1.1 - 1.2, notes 1.3 - 1.4, notes 1.5 - 1.6, notes 1.7 - 1.8, notes 1.8 - 1.9, notes 1.10 - 1.11, notes 1.11(cont) - 1.12, notes 1.13 - 1.17, notes 1.18 - 1.21
2.	The impact of the transition to Australian Equivalents to International Financial Reporting Standards from previous Australian Generally Accepted Accounting Principles - note 2
3.	Events after the balance sheet date - note 3
4A.	Revenues from Government - note 4A
4B.	Sales of goods and services - note 4B
4C.	Other revenue - note 4C
4D.	Other gains - note 4D
5A.	Employee expenses - note 5A
5B.	Supplier expenses - note 5B
5C.	Depreciation and amortisation expenses - note 5C
5D.	Write down of assets - note 5D
6A.	Cash - note 6A
6B.	Receivables - note 6B
7A.	Buildings - leasehold improvements - note 7A
7B.	Infrastructure, plant and equipment - note 7B
7C.	Analysis of property, plant and equipment - note 7C
7D.	Intangible assets - note 7D
7E.	Inventories - note 7E
7F.	Other non-financial assets - note 7F
8A.	Employee provisions - note 8A
9A.	Supplier payables - note 9A
9B.	Other payables - note 9B
10.	Cash flow reconciliation - note 10
11.	Financial instruments - note 11A, note 11A (cont.), note 11B, note 11C
12.	Contingent liabilities and assets - note 12
13.	Executive remuneration - note 13
14.	Remuneration of auditors - note 14
15.	Average staffing levels - note 15
16.	Act of Grace payments, waivers and defective administration scheme - note 16

Contents || Independent Audit Report (next page) >>